Allstate Corporation’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Allstate Corporation’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,282	Closed	-$715K	–	583
2022 Q4	$715K	Buy	+6,282	New	+$522K	0.02%	422
2022 Q3	–	Sell	-4,898	Closed	-$391K	–	632
2022 Q2	$391K	Sell	4,898 -13,020	-73%	-$1.23M	0.01%	543
2022 Q1	$1.89M	Buy	17,918 +14,221	+385%	+$1.39M	0.05%	261
2021 Q4	$398K	Sell	3,697 -194	-5%	-$21.2K	0.01%	698
2021 Q3	$426K	Sell	3,891 -650	-14%	-$67.5K	0.02%	544
2021 Q2	$425K	Sell	4,541 -469	-9%	-$43.2K	0.01%	567
2021 Q1	$461K	Buy	5,010 +510	+11%	+$43K	0.01%	560
2020 Q4	$329K	Buy	+4,500	New	+$334K	0.01%	598

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allstate Corporation's HZNP Position: Q1 2023 in Review

Allstate Corporation sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 6,282 shares — an estimated $715K sold.

Allstate Corporation first reported a position in HZNP in Q4 2020 and held it in 8 quarters. The position peaked at $1.89M in Q1 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Allstate Corporation reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Allstate Corporation sold 6,282 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $715K.
Allstate Corporation first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 8 quarters.
Allstate Corporation's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.89M in Q1 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Allstate Corporation's 13F filing for Q1 2023, filed 10 May 2023.